Matches in Wikidata for { <http://www.wikidata.org/entity/Q91860574> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q91860574 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q91860574 description "scientific article published on 01 April 2019" @default.
- Q91860574 description "wetenschappelijk artikel" @default.
- Q91860574 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q91860574 name "Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting" @default.
- Q91860574 name "Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting" @default.
- Q91860574 type Item @default.
- Q91860574 label "Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting" @default.
- Q91860574 label "Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting" @default.
- Q91860574 prefLabel "Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting" @default.
- Q91860574 prefLabel "Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting" @default.
- Q91860574 P1476 Q91860574-5667E45E-29A2-4994-8B63-AE4BC13CDD74 @default.
- Q91860574 P2093 Q91860574-26B15475-AFEC-41ED-912F-BB9C3E5BA1E9 @default.
- Q91860574 P2093 Q91860574-3195F79C-75B0-4393-896A-BF49CEB95CF1 @default.
- Q91860574 P2093 Q91860574-88AFD533-7255-4E7B-881C-AF5EAD8EF8AA @default.
- Q91860574 P2093 Q91860574-BE49D9FC-1535-4A36-84B0-4FA716728DF8 @default.
- Q91860574 P2093 Q91860574-F5F3C25B-3AC4-4510-8A33-6E9DF1B40BA0 @default.
- Q91860574 P304 Q91860574-5A0A31E3-5DF7-47E1-BEC1-F574BB755C91 @default.
- Q91860574 P31 Q91860574-63689A9D-6692-461D-AB53-8A26A3344FC9 @default.
- Q91860574 P356 Q91860574-BDDEAEDE-2921-40E4-B36A-8769918B2B5B @default.
- Q91860574 P433 Q91860574-12A4DED3-9859-4433-AB3B-993DD8FADDE5 @default.
- Q91860574 P478 Q91860574-65029216-0403-40CE-A62B-49B299741860 @default.
- Q91860574 P50 Q91860574-056246DB-D712-4DB2-82BE-21B6CC6DE503 @default.
- Q91860574 P50 Q91860574-BC89CA6C-8DA5-47A6-BB12-9C0E6169DF4A @default.
- Q91860574 P577 Q91860574-A5205647-CC70-475A-A50C-2E2649FF7CE3 @default.
- Q91860574 P698 Q91860574-D1E38B90-461B-4104-A219-F7ACCBF7DFAD @default.
- Q91860574 P921 Q91860574-F04A76E9-0D92-4DB5-8379-4A65F87619C1 @default.
- Q91860574 P356 15284336.2019.1628460 @default.
- Q91860574 P698 31303142 @default.
- Q91860574 P1476 "Dolutegravir plus rilpivirine as dual regimen in virologically suppressed HIV-1 infected patients in a clinical setting" @default.
- Q91860574 P2093 "Marta Monsalvo" @default.
- Q91860574 P2093 "María Fontecha" @default.
- Q91860574 P2093 "María Jesús Vivancos" @default.
- Q91860574 P2093 "Miguel A Rodriguez" @default.
- Q91860574 P2093 "Santiago Moreno" @default.
- Q91860574 P304 "64-72" @default.
- Q91860574 P31 Q13442814 @default.
- Q91860574 P356 "10.1080/15284336.2019.1628460" @default.
- Q91860574 P433 "2" @default.
- Q91860574 P478 "20" @default.
- Q91860574 P50 Q87367413 @default.
- Q91860574 P50 Q91418625 @default.
- Q91860574 P577 "2019-04-01T00:00:00Z" @default.
- Q91860574 P698 "31303142" @default.
- Q91860574 P921 Q937224 @default.